Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency

about

Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency

Item

http://www.wikidata.org/entity/Q58586459

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@en

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@nl

type

Item

label

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@en

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@nl

prefLabel

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@en

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@nl

P1476

Comparing Pathways of Bradykin ...... Due to C1 Inhibitor Deficiency

@en

P2093

Arnaud Bonnefoy

http://www.w3.org/2001/XMLSchema#string

Eric Wagner

http://www.w3.org/2001/XMLSchema#string

François Marceau

http://www.w3.org/2001/XMLSchema#string

Georges-Étienne Rivard

http://www.w3.org/2001/XMLSchema#string

Jacques Hébert

http://www.w3.org/2001/XMLSchema#string

Xavier Charest-Morin

http://www.w3.org/2001/XMLSchema#string

P2860

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model

Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues

Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.

Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality

Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease.

Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial.

P304

2183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.02183

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30333824

http://www.w3.org/2001/XMLSchema#string

P932

6176197

http://www.w3.org/2001/XMLSchema#string